---
title: "Patient Square Capital, LP: Score 88/100, Facts, Record and Sources"
canonical: "https://papertrailfinance.com/firms/patient-square-capital-312203"
as_of: 2026-11-02
updated: 2026-11-09
type: firm-profile
publisher: "The Paper Trail"
firm_type: "private-equity"
state: "CA"
city: "MENLO PARK"
rating: 88
sources:
  - name: "SEC's Investment Adviser Public Disclosure site"
    url: "https://adviserinfo.sec.gov/"
---

# Patient Square Capital, LP

Patient Square Capital, LP is a private equity firm headquartered in Menlo Park, California. It reports 30 private funds and $17.2 billion in gross fund assets. The Paper Trail scores it 88 out of 100 with high confidence, strongest on regulatory and disciplinary record and weakest on conflicts and related-party disclosure. Figures are as of Nov. 2, 2026. Information, not investment advice.

Patient Square Capital, LP: Private equity firm · Menlo Park, California · CRD 312203 · SEC file no. 801-120508. Source page: https://papertrailfinance.com/firms/patient-square-capital-312203

_Data as of Nov. 2, 2026, last read Nov. 9, 2026; SEC Form ADV bulk data file re-checked Nov. 11, 2026 with no change. Each fact below carries its own source and as-of date. Information, not investment advice._

Browse: [Private equity firms](https://papertrailfinance.com/private-equity) · [California](https://papertrailfinance.com/private-equity/california) · [Menlo Park](https://papertrailfinance.com/private-equity/california/menlo-park)

Key figures for Patient Square Capital, LP (each one's source, exact quote and as-of date are in the facts table below; data as of Nov. 2, 2026, last read Nov. 9, 2026; SEC Form ADV bulk data file re-checked Nov. 11, 2026 with no change):
- Gross fund assets: $17.2 billion
- Private funds: 30 private funds
- Registration: SEC-registered investment adviser
- Form ADV disciplinary items: None reported
- The Paper Trail rating: 88/100
- Among rated private equity firms: Higher than 16%

## How does The Paper Trail rate Patient Square Capital, LP?

Patient Square Capital, LP scores 88 out of 100 as a private equity firm, with high confidence, as of Nov. 2, 2026: higher than 16% of the 382 rated private equity firms that are ranked. 7 of 7 factors had enough evidence to score. 4 factors share the highest score, 10.0 of 10; the lowest is conflicts and related-party disclosure (6.5 of 10).

Patient Square Capital, LP's score combines regulatory and disciplinary record (15%), independent enforcement search (10%), fund safeguards (audit, custody, administration) (15%), conflicts and related-party disclosure (25%), disclosure consistency and timeliness (15%), filing transparency (10%) and registration history (10%). It says nothing about investment performance and is not advice.

Patient Square Capital, LP was scored on 100% of the rubric's weight. Every factor in the rubric was scored.

**Score factors for Patient Square Capital, LP as a private equity firm**

| Factor | Weight | Score (0-10) | Basis |
| --- | ---: | ---: | --- |
| Regulatory and disciplinary record | 15% | 10.0 | The firm reports no regulatory, criminal or civil disciplinary events on its Form ADV. |
| Independent enforcement search | 10% | 10.0 | A name search of the SEC's litigation releases and administrative proceedings and the CFTC's press releases found no matter involving this firm. |
| Fund safeguards (audit, custody, administration) | 15% | 8.5 | All 30 private funds are audited each year; all 30 audited funds use an independent, PCAOB-registered and inspected accountant; all 30 funds use an unrelated administrator and all 30 funds have an unrelated custodian. |
| Conflicts and related-party disclosure | 25% | 6.5 | The firm reports 3 scored conflict-of-interest practices on its Form ADV: recommending investments in which it has an ownership interest; using a brokerage owned by a related person; a related broker-dealer. |
| Disclosure consistency and timeliness | 15% | 10.0 | The firm's latest Form ADV was filed 5.5 months before the review date; all 28 funds that used Regulation D list a Form D file number. |
| Filing transparency | 10% | 10.0 | The firm lists a website, has 1 client brochure on file, gives name, size, investor count and auditor for all 30 funds. |
| Registration history | 10% | 9.3 | The firm's registration took effect 5.7 years ago; its legal name changed 0 times between 2016 and 2025. |

**Notes on how each factor was computed**

- Regulatory and disciplinary record: Form ADV Item 11 answered No for the firm and its advisory affiliates (the firm's own filing)
- Independent enforcement search: SEC lists + CFTC press releases searched, every hit reviewed; no resolved firm-level matter found beyond Form ADV

_Patient Square Capital, LP's score runs 0 to 100 and is computed from the factors above (a weighted mean of the scored factors, with N/A factors excluded). Missing data is never counted as good or bad; pending matters are shown but never scored; individuals are never rated._

- [How we rate private equity firms: the written rubric](https://papertrailfinance.com/private-equity/methodology)

_Source: The Paper Trail's scoring under the written rubric for private equity firms (/private-equity/methodology), from the sourced facts on this page; as of Nov. 2, 2026._

## What do public records say about Patient Square Capital, LP?

Patient Square Capital, LP's public records show gross fund assets of $17.2 billion, 30 private funds and registration as an SEC-registered investment adviser. They are among 64 sourced facts listed here as of Nov. 2, 2026. Each row gives its source, the exact quote or value read, and the date the source value is as of.

**Key facts about Patient Square Capital, LP as a private equity firm, with sources**

| Fact | Value | Source | As of |
| --- | --- | --- | --- |
| Registration type (SEC-registered adviser or exempt reporting adviser) | SEC-registered investment adviser | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (Listed in the SEC's registered-adviser roster (the SEC-registered adviser file); SEC status: Approved; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Date of the firm's latest Form ADV filing | May 26, 2026 | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“05/26/2026”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Months between the latest Form ADV filing and the review date | 5.5 months | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“May 26, 2026 to Nov. 9, 2026”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Number of private funds the firm reports | 30 private funds | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (Value as filed: 30; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Combined gross asset value of the firm's private funds | $17.2 billion | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“$17,222,347,814”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm reports any regulatory, criminal or civil disciplinary event | No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (Values as filed: Form ADV Item 11 (any disciplinary event): No; sub-questions 11A-11H answered Y: none; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Disciplinary question categories the firm answered Yes to | None listed | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“none”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |

**All other sourced facts (57)**

The other 57 sourced facts about Patient Square Capital, LP as a private equity firm, as of Nov. 2, 2026, each with its source and date.

**Other sourced facts about Patient Square Capital, LP as a private equity firm**

| Fact | Value | Source | As of |
| --- | --- | --- | --- |
| Disciplinary-history summary answer in the SEC data file | No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (Value as filed: Form ADV Item 11 (any disciplinary event): No; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Form ADV PDF with disciplinary detail pages was available and read | Yes | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (“PDF available”) | May 26, 2026 |
| Disciplinary detail pages in the firm's Form ADV | No disclosure pages | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Private funds read from the firm's Form ADV | 30 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (Computed from the Form ADV pages: 30 fund blocks) | May 26, 2026 |
| Funds audited each year | 30 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (Computed from the filing: 30 of 30 funds answered Yes) | May 26, 2026 |
| Funds with a readable audit answer | 30 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (Computed from the Form ADV pages: 30 funds) | May 26, 2026 |
| Audited funds with a readable auditor record | 30 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Audited funds whose every auditor is independent, PCAOB-registered and PCAOB-inspected | 30 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (“30 of 30”) | May 26, 2026 |
| Audited funds with a readable audit-opinion answer | 28 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Audited funds whose audit reports all carried unqualified opinions | 28 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (“28 of 28”) | May 26, 2026 |
| Funds with a readable administrator answer | 30 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Funds that use an administrator unrelated to the firm | 30 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Funds with a readable custodian answer | 30 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Funds that use a custodian unrelated to the firm | 30 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Hedge funds among the firm's funds | 0 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Hedge funds with a prime broker or an unrelated custodian | 0 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (“0 of 0”) | May 26, 2026 |
| Average share of fund assets valued by someone unrelated to the firm | 0% | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (“0.0% average over 30 funds”) | May 26, 2026 |
| Funds that use an outside marketer | 2 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Funds whose marketer is related to the firm | 0 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Funds that report relying on Regulation D | 28 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Of those, funds that list no Form D file number | 0 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Funds that report never relying on Regulation D | 2 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) | May 26, 2026 |
| Funds reported as never on Regulation D that have a Form D on EDGAR under the identical name | 0 | [sec.gov](https://www.sec.gov/data-research/sec-markets-data/form-d-data-sets) (“none matched”) | Nov. 9, 2026 |
| Form D file numbers the firm lists for its funds (shown, not scored) | 28 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (Computed from the Form ADV pages: 28 file numbers listed) | May 26, 2026 |
| Of those, file numbers found in EDGAR's Form D data sets (older filings are not included; shown, not scored) | 28 | [sec.gov](https://www.sec.gov/data-research/sec-markets-data/form-d-data-sets) (Found in EDGAR's Form D data sets: file number 021-403852 is PATIENT SQUARE EQUITY EXECUTIVES QP, LP (accession 0001868307-21-000001); file number 021-403858 is PATIENT SQUARE EQUITY EXECUTIVES, LP (accession 0001868307-21-000004); file number 021-403854 is PATIENT SQUARE EQUITY PARTNERS, LP (accession 0001868307-21-000002)) | Nov. 9, 2026 |
| Of those found, issuer name differs from the fund name (not scored: names change, so a different name is not by itself a mismatch) | 28 | [sec.gov](https://www.sec.gov/data-research/sec-markets-data/form-d-data-sets) (“01. PATIENT SQUARE EQUITY EXECUTIVES QP, LP vs PATIENT SQUARE EQUITY EXECUTIVES QP, LP; 02. PATIENT SQUARE EQUITY EXECUTIVES, LP vs PATIENT SQUARE EQUITY EXECUTIVES, LP; 03. PATIENT SQUARE EQUITY PARTNERS, LP vs PATIENT SQUARE EQUITY PARTNERS, LP”) | Nov. 9, 2026 |
| Share of funds audited each year | 30 of 30 funds have an annual audit | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (Counted from the fund pages of the firm's Form ADV (Schedule D, Section 7.B.(1))) | May 26, 2026 |
| Auditing firms named, with PCAOB status and funds audited | KPMG LLP: 28 funds, PCAOB-registered and inspected; KPMG: 1 fund, PCAOB-registered and inspected; KPMG LLC: 1 fund, PCAOB-registered and inspected | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (Counted from the fund pages of the firm's Form ADV (Schedule D, Section 7.B.(1))) | May 26, 2026 |
| Funds using an unrelated administrator and an unrelated custodian | 30 of 30 funds use an unrelated administrator; 30 of 30 funds use an unrelated custodian | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (Counted from the fund pages of the firm's Form ADV (Schedule D, Section 7.B.(1))) | May 26, 2026 |
| Funds whose administrator, custodian or marketer is related to the firm | Of 30 funds: 0 with a related administrator, 0 with a related custodian, 0 with a related marketer | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (Counted from the fund pages of the firm's Form ADV (Schedule D, Section 7.B.(1))) | May 26, 2026 |
| Funds and gross asset value by fund type | private equity fund: 30 funds; 17,222,347,814 gross asset value | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (Counted from the fund pages of the firm's Form ADV (Schedule D, Section 7.B.(1))) | May 26, 2026 |
| Funds with name, size, investor count and (if audited) auditor all disclosed | 30 | [reports.adviserinfo.sec.gov](https://reports.adviserinfo.sec.gov/reports/ADV/312203/PDF/312203.pdf) (“30 of 30”) | May 26, 2026 |
| Firm buys from or sells to clients as principal | No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“N”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm recommends investments in which it has an ownership interest | Yes | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“Y”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm executes agency cross trades | No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“N”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm recommends investments in which it has another sales interest | No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“N”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm uses a brokerage owned by a related person | Yes | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“Y”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm receives soft-dollar research or services | No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“N”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm pays others for client referrals | No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“N”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm is paid for client referrals | No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“N”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| All soft-dollar benefits fall within the legal safe harbor | Not disclosed | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“blank (not answered)”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Other conflict-of-interest answers (shown, not scored: near-universal for fund managers) | trades for itself securities it also recommends: Yes; recommends securities it underwrites or sponsors as general partner: No; discretion over which broker or dealer is used: Yes; recommends brokers or dealers to clients: Yes; a recommended broker or dealer is a related person: Yes; employee compensation tied to obtaining clients: No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“Form ADV Item 8 answers 8A(2), 8B(2), 8C(3), 8E, 8F and 8H(2), shown as filed; not scored (nearly every fund manager answers Yes)”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm has a related broker-dealer | Yes | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“Y”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm has a related insurance company or agency | No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“N”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm has a related bank or thrift | No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“N”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm has a related trust company | No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“N”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm says an independent accountant audits its pooled vehicles each year | Yes | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“Y”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm lists a website on its Form ADV | Yes | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“https://patientsquarecapital.com/”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Client brochures (Part 2A) on file at the SEC's adviser database | 1 | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (Value as filed: 1 brochure listed in the SEC's adviser database record) | Nov. 9, 2026 |
| Whether the SEC's database marks the firm exempt from filing a brochure | N | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) | Nov. 9, 2026 |
| Date the SEC status (registration or ERA report) took effect | March 15, 2021 | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“03/15/2021”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Years since the firm's SEC registration or exempt-adviser report took effect | 5.7 years | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“03/15/2021”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Legal-name changes across the yearly SEC snapshots, 2016 to 2025 | 0 | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (Computed from the yearly SEC snapshots: legal names across 5 yearly snapshots: PATIENT SQUARE CAPITAL, LP; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| Firm reports succeeding to another adviser's business (shown, not scored) | No | [adviserinfo.sec.gov](https://adviserinfo.sec.gov/firm/summary/312203) (“N”; read from the SEC's monthly adviser data file) | Nov. 2, 2026 |
| SEC and CFTC name search ran for this firm | Yes | [sec.gov](https://www.sec.gov/enforcement-litigation/litigation-releases) (“SEC litigation releases + administrative proceedings (1995-2026-11) and CFTC press releases searched by name (1 name form); 0 name hits, 0 official-site pages from web-search leads; 0 read against the primary document; 0 confirmed for this firm”) | Nov. 9, 2026 |
| Every name match checked against its original document | Yes | [sec.gov](https://www.sec.gov/enforcement-litigation/litigation-releases) (“SEC litigation releases + administrative proceedings (1995-2026-11) and CFTC press releases searched by name (1 name form); 0 name hits, 0 official-site pages from web-search leads; 0 read against the primary document; 0 confirmed for this firm”) | Nov. 9, 2026 |
| Matters confirmed in SEC or CFTC records | None listed apart from the firm's own Form ADV disclosure pages | [sec.gov](https://www.sec.gov/enforcement-litigation/litigation-releases) | Nov. 9, 2026 |

## What funds does Patient Square Capital, LP manage?

Patient Square Capital, LP reports 30 private funds with $17.2 billion in gross asset value on its Form ADV (Schedule D, Section 7.B.(1)), as of Nov. 2, 2026.

**Funds managed by Patient Square Capital, LP, by fund type**

| Fund type | Funds |
| --- | ---: |
| Private equity fund | 30 |

_Source: the firm's Form ADV, Schedule D Section 7.B.(1) (https://adviserinfo.sec.gov/firm/summary/312203); as of Nov. 2, 2026._

## How has Patient Square Capital, LP changed over the years?

Patient Square Capital, LP's regulatory assets rose from $630 million in 2021 to $12.0 billion in 2025. Patient Square Capital, LP's figures are from the SEC's yearly adviser files, 2021 to 2025, as reported.

**Patient Square Capital, LP by year**

| Year | Regulatory assets | Clients | Private funds | Private fund assets |
| --- | ---: | ---: | ---: | ---: |
| 2021 | $630 million | 5 | Not reported | Not reported |
| 2022 | $2.1 billion | 8 | Not reported | Not reported |
| 2023 | $4.9 billion | 15 | 15 | $4.9 billion |
| 2024 | $7.9 billion | 20 | 20 | $7.9 billion |
| 2025 | $12.0 billion | 26 | 26 | $11.9 billion |

## Is Patient Square Capital, LP registered, and who regulates it?

Registration or charter of Patient Square Capital, LP: SEC-registered investment adviser. Its regulator: SEC. Status in the regulator's record: Approved (SEC-registered adviser), since March 15, 2021 (SEC status effective date, Form ADV roster). CRD number: 312203; SEC file number 801-120508. No final regulatory action against the firm itself is on record in the sources read. Pending matters are listed separately and not counted. Record as of Nov. 2, 2026. Where to verify it: SEC adviser database (IAPD) firm page.

- [SEC adviser database (IAPD) firm page](https://adviserinfo.sec.gov/firm/summary/312203)

- [All firm types headquartered in California](https://papertrailfinance.com/states/california)

## Does Patient Square Capital, LP have a regulatory or legal record?

The Paper Trail found no regulatory, enforcement or legal items for Patient Square Capital, LP in the sources checked, as of Nov. 9, 2026. That is a statement about what was found in those records, not a guarantee; the sources are listed in the facts table.

## How can I check Patient Square Capital, LP myself?

To check Patient Square Capital, LP yourself, use the SEC's Investment Adviser Public Disclosure site. Search the firm's name or CRD number, open its summary, and read the latest Form ADV, including Item 11 (disciplinary information) and Schedule D for the funds it manages. Search with the identifier shown at the top of this page: CRD 312203 · SEC file no. 801-120508.

- [SEC Investment Adviser Public Disclosure (Form ADV)](https://adviserinfo.sec.gov/firm/summary/312203)

## How does Patient Square Capital, LP compare with other private equity firms in California?

Patient Square Capital, LP ranks 25 of 303 private equity firms headquartered in California in this dataset by gross fund assets ($17.2 billion); size is available for 302 of them.

**Patient Square Capital, LP and nearby private equity firms in California, ordered by gross fund assets**

| # | Firm | City | Gross fund assets | Score |
| ---: | --- | --- | ---: | ---: |
| 23 | [Alpine Investors](https://papertrailfinance.com/firms/alpine-investors-157255) | San Francisco | $18.9 billion | 91 |
| 24 | [Westbridge Capital US Advisors, LP](https://papertrailfinance.com/firms/westbridge-capital-us-advisors-161527) | San Mateo | $17.2 billion | 90 |
| 25 | Patient Square Capital, LP | Menlo Park | $17.2 billion | 88 |
| 26 | [Paradigm Operations LP](https://papertrailfinance.com/firms/paradigm-operations-299210) | San Francisco | $14.8 billion | 91 |
| 27 | [TSG Consumer Partners LP](https://papertrailfinance.com/firms/tsg-consumer-partners-160826) | Larkspur | $14.3 billion | 94 |

## Which related firms are in the dataset?

Five other firms in this dataset are related to Patient Square Capital, LP: 3 private equity firms of similar size in California and 2 firms of another kind in Menlo Park. Each is listed with its headquarters and kind of firm:

- [Paradigm Operations LP, San Francisco, CA: private equity firm](https://papertrailfinance.com/firms/paradigm-operations-299210)
- [TSG Consumer Partners LP, Larkspur, CA: private equity firm](https://papertrailfinance.com/firms/tsg-consumer-partners-160826)
- [STG Partners, LLC, Menlo Park, CA: private equity firm](https://papertrailfinance.com/firms/stg-partners-291048)
- [Andreessen Horowitz, Menlo Park, CA: venture capital firm also in Menlo Park](https://papertrailfinance.com/firms/andreessen-horowitz-160489)
- [Sequoia Capital Operations, LLC, Menlo Park, CA: venture capital firm also in Menlo Park](https://papertrailfinance.com/firms/sequoia-capital-operations-157373)

## How is the score calculated?

Patient Square Capital, LP is assessed under the written rubric for its firm type. A factor is scored 0 to 10 from sourced facts, each factor has a published weight, factors without enough evidence are excluded and the rest are re-weighted, and a score is published only when the rubric's publication gate is met and the record's facts have been checked a second time (how Patient Square Capital, LP's facts were checked is under "Where does this information come from?").

- [How we rate private equity firms](https://papertrailfinance.com/private-equity/methodology)

## Where does this information come from?

The 64 fact rows about Patient Square Capital, LP in the tables above come from 3 public sources. The source values are dated May 26, 2026 to Nov. 9, 2026. The day each source was read for this firm is listed below. Nothing here comes from the firm's marketing unless a fact says so, and each fact's source and exact quote are in its row. Second check: 117 underlying values behind these fact rows were recomputed from the regulator's data files by a second, separately written program on Nov. 9, 2026, and they matched.

- [adviserinfo.sec.gov: 30 facts](https://adviserinfo.sec.gov/)
- [reports.adviserinfo.sec.gov: 28 facts](https://reports.adviserinfo.sec.gov/)
- [sec.gov: 6 facts](https://www.sec.gov/)

- Form ADV PDF (SEC adviser database), read Nov. 9, 2026 (29 facts)
- SEC Form ADV bulk data file, read Nov. 9, 2026; re-checked Nov. 11, 2026 with no change (29 facts)
- SEC litigation releases and administrative proceedings, read Nov. 9, 2026 (6 facts)
- SEC adviser database (IAPD) record, read Nov. 9, 2026 (2 facts)
